Company intelligence / Profile preview
Precisio Biotix Therapeutics
Dover, Delaware, United Statesprecisiobiotix.com ↗
- Ownership
- Private
- Development stage
- Clinical
01
Overview
Precisio Biotix is developing novel precision biological antibacterials with a focus on lung and skin infections. The company has a pipeline of lysin and phage products targeting antimicrobial-resistant infections.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Lysins (engineered precision enzymes)bacteriophages (phages)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Mayo ClinicCC Bio (acquired)
Beyond the preview
Go deeper on Precisio Biotix Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Precisio Biotix Therapeutics.